CClinicalTrials.gg
Sign In
CompletedNCT06623747LEARUpdated Feb 12, 2026

Low Energy Availability and Recovery From Resistance Exercise

An interventional study of Diet and Diet in Resistance Exercise, sponsored by Chaise Murphy. Completed at 1 site in United States. Open to male participants aged 18 Years to 30 Years. Per ClinicalTrials.gov, last updated 2026-02-12.

Sponsored by Chaise Murphy · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
8
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
Male
01

Study summary

This research project will determine how restricting Calories to lose weight affects your ability to recover between weightlifting exercise sessions.

02

Conditions studied

  • Resistance Exercise
03

In context

Lead sponsor

This is the only study on the registry with Chaise Murphy as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Inclusion criteria

  • 3 years of resistance training experience

Exclusion criteria

Exclusion Criteria:

  • 1+ American College of Sports Medicine sign(s) or symptom(s) of cardiovascular, metabolic or renal disease(s)
  • musculoskeletal disorder(s)
  • lactose intolerance; soy or dairy allergies
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
8 participants (actual)

Study arms

  • Active comparator
    CONTROL

    Behavioral: Diet

  • Experimental
    LOW ENERGY AVAILABILITY

    Behavioral: Diet

Interventions

  • BehavioralDiet

    15 kcal per kg fat-free mass

  • BehavioralDiet

    45 kcal per kg fat-free mass

06

What researchers measure

Primary outcomes

  1. Vertical Jump Performance

    Time frame: At enrollment (baseline), wait 1-2 weeks, before and after first 2-day condition, wait 1-2 weeks, before and after second 2-day condition

  2. Knee Extension and Flexion Repetitions to Failure

    Time frame: At enrollment (baseline), wait 1-2 weeks, before and after first 2-day condition, wait 1-2 weeks, before and after second 2-day condition

  3. Bench Press One-Repetition Maximum

    Time frame: At enrollment (baseline), wait 1-2 weeks, before and after first 2-day condition, wait 1-2 weeks, before and after second 2-day condition

  4. Peak Knee Extension and Flexion Torques

    Time frame: At enrollment (baseline), wait 1-2 weeks, before and after first 2-day condition, wait 1-2 weeks, before and after second 2-day condition

07

Study locations

1 site
  • South Dakota State University
    Brookings, South Dakota 57006, United States
08

References and documents

Individual participant data

Plan to share: No — As of right now, I have no collaborators to share the data with.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06623747
Lead sponsor
Chaise Murphy
Collaborators
South Dakota State University
Responsible party
Chaise Murphy (Assistant Professor of Exercise Science, South Dakota State University) — Sponsor-investigator
First posted
Oct 2, 2024
Start date
Jul 19, 2024
Primary completion
Dec 20, 2024
Completion
Dec 20, 2024
Last update
Feb 12, 2026

Study contacts

Chaise A Murphy, Ph.D.
principal investigator · South Dakota State University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion